학술논문

A phase 1 study of triple-targeted therapy with BRAF, MEK, and AKT inhibitors for patients with BRAF-mutated cancers
Document Type
Article
Source
In: Cancer. (Cancer, 15 May 2024, 130(10):1784-1796)
Subject
Language
English
ISSN
10970142
0008543X